Oral immunotherapy for peanut allergy in clinical practice is ready

Allergy and Asthma Proceedings

Volumn 34, Issue 3, 2013, Pages 205-209

  Mansfield, Lyndon E ^a,b  

^a Texas Tech University Health Sciences Center El Paso   (United States)

^b Western Sky Medical Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; IMMUNOGLOBULIN E;

ANAPHYLAXIS; CLINICAL PRACTICE; CONFERENCE PAPER; DESENSITIZATION; EOSINOPHILIC ESOPHAGITIS; FOOD ALLERGY; HUMAN; ORAL IMMUNOTHERAPY; PEANUT ALLERGY; PRIVATE PRACTICE; PSYCHOSOCIAL DISORDER; QUALITY OF LIFE; REMISSION; SOCIALIZATION;

ADMINISTRATION, ORAL; DESENSITIZATION, IMMUNOLOGIC; HUMANS; PEANUT HYPERSENSITIVITY; PRIVATE PRACTICE; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84878336725     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2013.34.3666     Document Type: Conference Paper

References (35)

1. Ridolo E, De Angelis G, and Dall'aglio P. Eosinophilic esophagitis after specific oral tolerance induction for egg protein. Ann Allergy Asthma Immunol 106: 73-74, 2011.
2. Sanchez Garcia S, Rodriguez Del Rio P, Escudero C, and Martinez Gomez MJ. Possible eosinophilic esophagitis induced by milk oral immunotherapy. J Allergy Clin Immunol 29: 1156-1157, 2011.
3. Thyagarajan A, Pooja V, Jones SM, et al. Peanut oral immunotherapy is not ready for clinical use. J Allergy Clin Immunol 126: 31-22, July 2009.
4. Sicherer SH, Munoz-Furlong A, Godbold JH, and Sampson HA. US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. J Allergy Clin Immunol 125: 1322-1326, 2010.
5. Akeson N, Worth A, and Sheikh A. The psychological impact of anaphylaxis on young people and their parents. Clin Exp Allergy 37: 1213-1220, 2007.
6. Neuman-Sunshine DL, Eckman JA, Keet CA, et al. The natural history of persistent peanut allergy. Ann Allergy Asthma Immunol 108: 326-333, 2012.
7. Jarvinen KM. Food-induced anaphylaxis. Curr Opin Allergy Clin Immunol 11: 255-261.
8. Koplin JJ, Martin PE, and Allen KJ. An update on epidemiology of anaphylaxis in children and adults. Curr Opin Allergy Clin Immunol 11: 492-496.
9. Yocum MW, Butterfield JH, Klein JS, et al. Epidemiology of anaphylaxis in Olmeted County: A population-based study. J Allergy Clin Immunol 104: 452-456, 1999.
10. Rinaldi M, Harnack L, Oberg C, et al. Peanut allergy diagnoses among children residing in Olmsted County, Minnesota. J Allergy Clin Immunol 130: 945-950, 2012.
11. Patel DA, Holdford DA, Edwards E, and Carroll NV. Estimating the economic burden of food-induced allergic reactions and anaphylaxis in the United States. J Allergy Clin Immunol 128: 110-115, 2011.
12. Pumphrey R. When should self-injectable epinephrine be prescribed for food allergy and when should it be used? Curr Opin Allergy Clin Immunol 8: 254-260, 2008.
13. Sicherer SH, and Simons FE.. Quandaries in prescribing an emergency action plan and self-injectable epinephrine for firstaid management of anaphylaxis in the community. J Allergy Clin Immunol 115: 575-583, 2005.
14. Bock SA, Munoz-Furlong A, and Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol 119: 1016-1018, 2007.
15. Pumphrey R. Anaphylaxis: Can we tell who is at risk of a fatal reactioñCurr Opin Allergy Clin Immunol 4: 285-290, 2004.
16. Sampson MA, Munoz-Furlong A, and Sicherer SH. Risk-taking and coping strategies of adolescents and young adults with food allergy. J Allergy Clin Immunol 117: 1440-1445, 2006.
17. Springston EE, Smith B, Shulruff J, et al. Variations in quality of life among caregivers of food allergic children. Ann Allergy Asthma Immunol 105: 287-294, 2010.
18. Primeau MN, Kagan R, Joseph L, et al. The psychological burden of peanut allergy as perceived by adults with peanut allergy and the parents of peanut-allergic children. Clin Exp Allergy 30: 1135-1143, 2000.
19. Cummings AJ, Knibb RC, Erlweyn-Lajeunesse M, et al. Management of nut allergy influences quality of life and anxiety in children and their mothers. Pediatr Allergy Immunol 21: 586 -594, 2010.
20. Sicherer SH, Noone SA, and Munoz-Furlong A. The impact of childhood food allergy on quality of life. Ann Allergy Asthma Immunol 87: 461-464, 2001.
21. Lieberman JA, and Sicherer SH. Quality of life in food allergy. Curr Opin allergy Clin Immunol 11: 236-242.
22. Keston BM, Waters I, Hopkins JG. Oral desensitizations the common foods. J Allergy. 6: 428-431, 1935.
23. Edwards HE. Oral desensitization in food allergy. Can Med Assoc J 31: 234-236, 1942.
24. Tuft L. V. Methods and principles of treatment. In Clinical Allergy. Philadelphia, PA, and London: W.B. Saunders, Vaughn W and Black HJ (Eds)., 178-179, 1937.
25. Tuft L. VII. Food allergy. In Clinical Allergy. Philadelphia, PA, and London: W.B. Saunders, Vaughn W and Black HJ (Eds)., 615-619, 1937.
26. Vaughn W, and Black HJ. XXXIV. The treatment of food allergy. In Practice of Allergy. St. Louis, MO: C.V. Mosby Co., Vaughn W and Black HJ (Eds), 328-330, 1948.
27. Patriarca G, Nucera E, Roncallo C, et al. Oral desensitizing treatment in food allergy: clinical and immunological results. Aliment Pharmacol Ther 17: 459-465, 2003.
28. Sicherer SH, and Sampson HA. Peanut allergy: Emerging concepts and approaches for an apparent epidemic. J. Allergy Clinic Immunol 120: 491-503, 2007 .
29. Sheikh A, Venderbosch I, and Nurmatov U. Oral immunotherapy for peanut allergy. Br Med J 340:c2938, 2010.
30. Gallucci AR, Wasserman RL, Sugerman RW, et al. Oral immunotherapy (OIT) of food allergy (FA) successfully desensitizes most patients. J Allergy Clin Immunol 127:83 (Abs), 2010.
31. Factor JM, Mendelson L, Lee J, et al. Effect of oral immunotherapy to peanut on food specific quality of life. Ann Allergy Asthma Immunol. 109: 348-352, 2012.
32. Hofmann AM, Scurlock AM, Jones SM, et al. Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol 124: 286-291, 2009.
33. Wasserman RL, Sugerman RW, Mireku-Akomeah N, et al. Peanut oral immunotherapy (OIT) of food allergy (FA) carries a significant risk of eosinophilic esophagitis (EoE). J Allergy Clin Immunol 127:AB15, 2011 (Abs).
34. Thyagarajan A, Varshney P, Jones SM, et al. Peanut oral immunotherapy (OIT) is not ready for clinical use. J Allergy Clin Immunol 126: 31-32, 2010.
35. Sampson HA. Peanut oral immunotherapy: Is it ready for clinical practice? J Allergy Clin Immunol: In Practice 1: 15-21, 2013.